Evidence map›Paper›PMID 35783851›Full record

ArticleFrontiers in cardiovascular medicine2022

Machine Learning Patient-Specific Prediction of Heart Failure Hospitalization Using Cardiac MRI-Based Phenotype and Electronic Health Information.

Aidan K Cornhill, Steven Dykstra, Alessandro Satriano, Dina Labib, Yoko Mikami, Jacqueline Flewitt, Easter Prosio, Sandra Rivest, Rosa Sandonato, Andrew G Howarth and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Aidan K CornhillStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
Steven DykstraStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
Alessandro SatrianoStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
Dina LabibStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
Yoko MikamiStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
Jacqueline FlewittStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
Easter ProsioStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
Sandra RivestStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
Rosa SandonatoStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
Andrew G HowarthStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
Carmen LydellStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
Cathy A EastwoodLibin Cardiovascular Institute of Alberta, Calgary, AB, Canada.
Hude QuanLibin Cardiovascular Institute of Alberta, Calgary, AB, Canada.
Nowell FineDivision of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, Calgary, AB, Canada.
Joon LeeDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
James A WhiteStephenson Cardiac Imaging Centre, University of Calgary, Calgary, AB, Canada.
University of Calgary · CALibin Cardiovascular Institute of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Heart failure (HF) hospitalization is a dominant contributor of morbidity and healthcare expenditures in patients with systolic HF. Cardiovascular magnetic resonance (CMR) imaging is increasingly employed for the evaluation of HF given capacity to provide highly reproducible phenotypic markers of disease. The combined value of CMR phenotypic markers and patient health information to deliver predictions of future HF events has not been explored. We sought to develop and validate a novel risk model for the patient-specific prediction of time to HF hospitalization using routinely reported CMR variables, patient-reported health status, and electronic health information. Methods: Standardized data capture was performed for 1,775 consecutive patients with chronic systolic HF referred for CMR imaging. Patient demographics, symptoms, Health-related Quality of Life, pharmacy, and routinely reported CMR features were provided to both machine learning (ML) and competing risk Fine-Gray-based models (FGM) for the prediction of time to HF hospitalization. Results: The mean age was 59 years with a mean LVEF of 36 ± 11%. The population was evenly distributed between ischemic (52%) and idiopathic non-ischemic cardiomyopathy (48%). Over a median follow-up of 2.79 years (IQR: 1.59-4.04) 333 patients (19%) experienced HF related hospitalization. Both ML and competing risk FGM based models achieved robust performance for the prediction of time to HF hospitalization. Respective 90-day, 1 and 2-year AUC values were 0.87, 0.83, and 0.80 for the ML model, and 0.89, 0.84, and 0.80 for the competing risk FGM-based model in a holdout validation cohort. Patients classified as high-risk by the ML model experienced a 34-fold higher occurrence of HF hospitalization at 90 days vs. the low-risk group. Conclusion: In this study we demonstrated capacity for routinely reported CMR phenotypic markers and patient health information to be combined for the delivery of patient-specific predictions of time to HF hospitalization. This work supports an evolving migration toward multi-domain data collection for the delivery of personalized risk prediction at time of diagnostic imaging.

Indexed as

cardiovascular magnetic resonance imagingheart failure hospitalizationmachine learningpredictionsystolic heart failure (HF)

Identifiers

PMID35783851
PMCPMC9245012
OpenAlexW4282964896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.